K-pop

Cat's Eye's "Animal" Ranks No. 18 on the UK Official Singles Chart… Remains in the Top Ranks for the Second Week

Collaboration Track Enters the Charts… Gaining Traction in the UK Kedehun OST “Golden” Ranks 49th… Remains on the Charts for 59 Weeks

YUN GI BACK
2026-08-08 11:27:52
[Edaily Starin YUN GI BACK Reporter] The group KATSEYE continued its global success by maintaining a top position on the UK Official Singles Chart with their new song “ANIMAL.”
KATSEYE (Photo: HYBE·Geffen Records)

According to the UK Official Charts released on the 7th (local time), KATSEYE’s “ANIMAL” ranked 18th on the Official Singles Top 100. Although it dropped two spots from the previous week, it remained in the upper ranks of the chart for two consecutive weeks, demonstrating its steady popularity.
Cat’s Eye also placed another new song, “ICONIC BY MISTAKE,” on the chart. This track, a collaboration with HYBE’s girl groups LE SSERAFIM and ILLIT, made its presence known by debuting at No. 85.
Meanwhile, “GOLDEN,” a track from the original soundtrack (OST) of the Netflix animated series “K-Pop Demon Hunters,” continued its long-running success by ranking at No. 49. It has now remained on the chart for an impressive 59 consecutive weeks.

Economy

Corporation

IT·Science

Economy

"AI Broadcasts on Its Own"... A Creator Startup Founded by a Former TikTok Employee [VC Cradle]

A virtual creator that doesn’t require a human actor has emerged. There is no pre-written script, nor is there an operator manipulating it in real time. Artificial intelligence (AI) hosts the broadcas…
2026-08-08 11:01:04

Corporation

Mezzion Pharma Co., Ltd. Simultaneously Improves Cysts and Kidney Function in ADPKD… “Moving Directly to Phase 2b Clinical Trials in Korea and the U.S.”

“When you examine the kidneys of mice with polycystic kidney disease, you can see large cysts. However, after administering Udenafil, a reduction in the size of these cysts was visible even to the nak…
2026-08-08 08:16:01

IT·Science

SK BIOPHARMACEUTICALS Soars on Cenobamate Growth… The Era of 45% Generic Drug Prices Begins [Weekly Bio Roundup]

(Graphic: Generative AI) During the first week of August (August 3–7), SK BIOPHARMACEUTICALS posted its best-ever quarterly earnings, driven by the growth of its new epilepsy drug “cenobamate.” Ad…
2026-08-08 08:31:03